Free shipping on all orders over $ 500

GSK621

Cat. No. M8761

All AbMole products are for research use only, cannot be used for human consumption.

GSK621 Structure
Size Price Availability Quantity
1mg USD 55 In stock
5mg USD 135 In stock
10mg USD 220 In stock
25mg USD 420 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

GSK621 is a direct AMPK activator that exhibits anti-leukemic (300 μM; MOLM-14, HL-60, OCI-AML3) and anti-glioma (Effec. conc. 10-100 μM; U87MG and U251MG) activity, while displaying little cytotoxicity toward normal hematopoietic progenitors, primary human astrocytes, or HCN-1a neuronal cells. When administered via intraperitoneal injection, GSK621 (30 mg/kg twice daily) is shown to reduce leukemia growth and significantly extend the survival of mice xenografted with MOLM-14 cells. AMPK activation by GSK621 leads to mTOR inhibition and Tetraspanin 8 (Tspan8) downregulation in glioma cells, while GSK621-induced cytotoxicity in acute myeloid leukemia (AML) cells is the result of synthetic lethality, where co-activation of AMPK and mTORC1 activates the eIF2a signaling pathway, which in turn triggers autophagic cell death.

Chemical Information
Molecular Weight 489.91
Formula C26H20ClN3O5
CAS Number 1346607-05-3
Solubility (25°C) DMSO: 2 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Li Ting-Ting, et al. GSK621 attenuates oxygen glucose deprivation/re-oxygenation-induced myocardial cell injury via AMPK-dependent signaling

[2] Weidong Liu, et al. Targeted activation of AMPK by GSK621 ameliorates H2O2-induced damages in osteoblasts

[3] Lezi Chen, et al. AMPK activation by GSK621 inhibits human melanoma cells in vitro and in vivo

[4] Yong-Hong Wu, et al. GSK621 activates AMPK signaling to inhibit LPS-induced TNFα production

[5] Hong Jiang, et al. GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase Signalings

Related AMPK Products
Dorsomorphin dihydrochloride

Dorsomorphin (BML-275; Compound C) dihydrochloride is a potent inhibitor of AMP-activated protein kinase (AMPK), with a Ki of 109 nM. Dorsomorphin dihydrochloride inhibits BMP pathway by targeting the type I receptors ALK2, ALK3, and ALK6. Dorsomorphin dihydrochloride induces autophagy.

OTSSP167

OTSSP167 is a highly potent MELK (maternal embryonic leucine zipper kinase) inhibitor with IC50 of 0.41 nM.

WZ4003

WZ4003 is a highly specific NUAK kinase inhibitor with IC50 of 20 nM and 100 nM for NUAK1 and NUAK2, respectively, without significant inhibition on 139 other kinases.

Geniposide

Geniposide is an iridoid glycoside isolated from the fruit of Gardenia jasminoides Ellis.

Metformin

Metformin (1, 1-dimethylbiguanide) inhibits mitochondrial respiratory chains in the liver, leads to AMPK activation and enhances insulin sensitivity, and can be used in type 2 diabetes research. Metformin can cross the blood-brain barrier and induce autophagy, and Metformin is a CD47 inhibitor in vitro.

  Catalog
Abmole Inhibitor Catalog




Keywords: GSK621 supplier, AMPK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.